Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc. is a biopharmaceutical company based in The Woodlands, Texas. The company employs 412 people and generates $322 million in annual revenue. Lexicon Pharmaceuticals specializes in leveraging genetic information to discover new drugs. Their research focuses on identifying novel drug candidates through gene knockout technology, which allows them to understand target biology and pinpoint potential interventions for various diseases. Lexicon's scientists utilize recombinant DNA and chemistry technologies to systematically develop drug candidates. The company's comprehensive knowledge of the human genome enables them to evaluate and advance promising therapies for a wide range of conditions. Lexicon Pharmaceuticals' drug discovery pipeline encompasses a diverse array of targeted therapies for diseases with significant unmet medical needs. The company's drug candidates are internally developed, designed to specifically target points within genetically-defined pathways involved in disease processes. Their research spans conditions affecting millions, such as diabetes, as well as rarer diseases like carcinoid syndrome, for which treatment options are limited. For more information about Lexicon Pharmaceuticals and its innovative drug discovery approach, visit their website at lexpharma.com.